Cancer Research

Herausgeber

Amer Assoc Cancer Research

International Standard Serial Number (ISSN )

0008-5472

Electronic International Standard Serial Number ( EISSN )

1538-7445

ISSN gedruckt

0008-5472

URL

http://www.bibliothek.uni-regensburg.de/ezeit/?2036785

Weitere Details

2020

A potent and selective small molecule degrader of STAT5 for the treatment of hematological malignancies.

2020

Active immunization with PD1-derived mimotope-Combination immunotherapy against Her-2/neu-expressing tumors.

2020

Restoration of tumor immunosurveillance in tasmanian devil facial tumor disease.

2020

The gain-of-function STAT5B(N642H) mutation as a driver of mature T cell leukemia/lymphoma.

2020

Xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, shows efficacy in a human breast cancer model of bone metastasis.

2019

Targeting YAP/TAZ pathway inhibits Ewing sarcoma metastasis.

2018

Inhibition of the Hif1a-mediated checkpoint refuels NK activation in cancer.

2017

CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.

2017

The coactivator oncogene AF1Q associates with STAT3 activation downstream of MET action in gastro-esophageal cancer patients.

2016

ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.

2016

Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells.

2014

A mouse model for small round cell tumors induced by the Ewing sarcoma oncogene EWS/FLI1.

2014

The role of growth hormone receptor in liver fibrosis and cancer.

2013

Skin tumorigenesis stimulated by Raf inhibitors relies upon Raf functions that are dependent and independent of ERK.

2013

Role of the guanylate-binding-protein 1 (GBP-1) in immunoediting of colorectal carcinoma.

2012

The growing arsenal of ATP-competitive and allosteric inhibitors of BCR-ABL.

2010

Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

2009

Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.

2009

Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.

2009

Potential impact of hepatic lipid peroxidation on tumor promotion in rats exposed to rancid fat.

2008

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.

2005

Mouse mammary tumor virus infects human cells.

Kenner, Lukas
2014
Jensen-Jarolim, Erika
2012

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format

2020

A potent and selective small molecule degrader of STAT5 for the treatment of hematological malignancies.

2020

Active immunization with PD1-derived mimotope-Combination immunotherapy against Her-2/neu-expressing tumors.

2020

Restoration of tumor immunosurveillance in tasmanian devil facial tumor disease.

2020

The gain-of-function STAT5B(N642H) mutation as a driver of mature T cell leukemia/lymphoma.

2020

Xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, shows efficacy in a human breast cancer model of bone metastasis.

2019

Targeting YAP/TAZ pathway inhibits Ewing sarcoma metastasis.

2018

Inhibition of the Hif1a-mediated checkpoint refuels NK activation in cancer.

2017

CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.

2017

The coactivator oncogene AF1Q associates with STAT3 activation downstream of MET action in gastro-esophageal cancer patients.

2016

ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.

2016

Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells.

2014

A mouse model for small round cell tumors induced by the Ewing sarcoma oncogene EWS/FLI1.

2014

The role of growth hormone receptor in liver fibrosis and cancer.

2013

Skin tumorigenesis stimulated by Raf inhibitors relies upon Raf functions that are dependent and independent of ERK.

2013

Role of the guanylate-binding-protein 1 (GBP-1) in immunoediting of colorectal carcinoma.

2012

The growing arsenal of ATP-competitive and allosteric inhibitors of BCR-ABL.

2010

Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

2009

Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.

2009

Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.

2009

Potential impact of hepatic lipid peroxidation on tumor promotion in rats exposed to rancid fat.

2008

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.

2005

Mouse mammary tumor virus infects human cells.

Kenner, Lukas
2014
Jensen-Jarolim, Erika
2012

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format